Abstract:

Objective To evaluate the feasibility and effectiveness of enhanced recovery after surgery (ERAS) in minimally invasive surgery for adrenal tumors. Methods A total of 139 patients underwent retroperitoneal laparoscopic adrenalectomy were selected in this study. The maximum tumor diameter was ≤ 6.0 cm. According to the perioperative plan, patients were divided into the ERAS group (n=65) and the conventional group (n=74). The general information (age, gender, tumor location and tumor diameter), surgical indicators (surgical time and surgical blood loss), postoperative rehabilitation indicators (first off-bed ambulation time, first exhaust time, postoperative catheterization time, postoperative drainage tube retention time and postoperative hospitalization time) and incidence of complications were compared between two groups of patients. Results There were no significant differences in gender, age, tumor location, tumor diameter, surgical time and surgical blood loss between the two groups of patients (P>0.05). In the ERAS group, first off-bed ambulation time, first exhaust time, the indwelling duration of catheters and drainage tubes were shorter than those in the conventional group, and the overall incidence of postoperative complications was lower in the ERAS group than that in the conventional group (P<0.05). Conclusion The ERAS protocol is safe and feasible for minimally invasive surgery in patients with adrenal tumors with a maximum tumor diameter of ≤ 6.0 cm.

Key words: enhanced recovery after surgery, laparoscopy, adrenal gland neoplasms, perioperative period, retroperitoneal laparoscopy